Juan Vilaro, MD
Cardiovascular Disease · Gainesville, FLNPI 1033316948
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 95.4% of the total across 12 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 8 manufacturers reported payments, led by Abiomed at 50.3% of the total. Reporting peaked in 2024 at $344 and has fallen 59.6% since, to $139 in 2025. That places this record below the midpoint for cardiovascular disease clinicians in FL, where the typical reported total is $2,774.
Across 12 payments — averaging $77.65 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abiomed$469
- Cvrx, Inc.$125
- Medtronic$108
- Merck$103
- Neotract Inc.$55
- Teleflex LLC$32
- plus $39 from 2 others
Across 20 payments — averaging $7703.16 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Novartis$77K
- AstraZeneca$48K
- Merck$28K
What the payments were for
- Food & beverage$88995%
- Education$435%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abiomed | 5 | $469 |
| Cvrx, Inc. | 1 | $125 |
| Medtronic | 1 | $108 |
| Merck | 1 | $103 |
| Neotract Inc. | 1 | $55 |
| Teleflex LLC | 1 | $32 |
| Johnson & Johnson | 1 | $28 |
| Pfizer | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Impella$247
- VERQUVO$207
- Barostim Neo System$125
- Amplia MRI$108
How this compares
$932 in reported general payments places this provider in the 25th percentile of 1,740 cardiovascular disease providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other cardiovascular disease in Gainesville
- Juan ArandaGainesville$212K
- Keith MarchGainesville$176K
- Ann TongGainesville$160K
- Carlos Alviar RestrepoGainesville$104K
- Michael KorenGainesville$97K
- Kevin MakatiLutz$1.6M
- Hiram BezerraTampa$698K
- William OneillNaples$637K
- Theodore FeldmanMiami$637K
- John Gerald CantoLakeland$588K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.